Nifedipine Bioavailability Study With Oral Single Doses Under Fasting and Fed Conditions
Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
The present study will be performed to investigate and to compare the in-vivo performance of
the two investigational products Gen-nifedipine extended release, (previously referred to as
Gen-Nifedipine XL (Genpharm ULC, Canada)) and Nifedipine(Bayer Healthcare AG manufactured as
Adalat® XL®, Adalat® LA, Adalat® Crono, Adalat® OROS) by comparing their pharmacokinetic
parameters after oral single dose administrations in the fasted and fed state.